INTRACRINE DYNAMICS OF CYP17A1 ACTIVITIES IN HUMAN CASTRATION RESISTANT PROSTATE CANCER

被引：0
|
作者：
Kosaka, Takeo
Miyajima, Akira
Maeda, Takahiro
Nagata, Hirohiko
Yasumizu, Yota
Kikuchi, Eiji
Oya, Mototsugu
机构：
来源：
JOURNAL OF UROLOGY | 2013年 / 189卷 / 04期
关键词：
D O I：
10.1016/j.juro.2013.02.1900
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
506
引用
收藏
页码：E207 / E208
页数：2
相关论文
共 50 条
  • [31] HSD3B1 AND RESISTANCE TO CYP17A1 INHIBITION IN PROSTATE CANCER
    Reichard, Chad
    Almassi, Nima
    Russell, Carly
    Li, Jianbo
    Friedlander, Terence
    Sharifi, Nima
    JOURNAL OF UROLOGY, 2016, 195 (04): : E77 - E77
  • [32] Prostate cancer androgen biosynthesis relies solely on CYP17A1 downstream metabolites
    Snaterse, Gido
    Taylor, Angela E.
    Moll, J. Matthijs
    O'Neil, Donna M.
    Teubel, Wilma J.
    van Weerden, Wytske M.
    Arlt, Wiebke
    Hofland, Johannes
    JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2024, 236
  • [33] CYP17A1 inhibitors in prostate cancer: mechanisms of action independent of the androgenic pathway
    Audenet, F.
    Murez, T.
    Ripert, T.
    Villers, A.
    Neuzillet, Y.
    PROGRES EN UROLOGIE, 2013, 23 : S9 - S15
  • [34] Morusflavone, a New Therapeutic Candidate for Prostate Cancer by CYP17A1 Inhibition: Exhibited by Molecular Docking and Dynamics Simulation
    Abdi, Sayed Aliul Hasan
    Ali, Amena
    Sayed, Shabihul Fatma
    Ahsan, Mohamed Jawed
    Tahir, Abu
    Ahmad, Wasim
    Shukla, Shatrunajay
    Ali, Abuzer
    PLANTS-BASEL, 2021, 10 (09):
  • [35] Comparisons of Prostate Cancer Inhibitors Abiraterone and TOK-001 Binding with CYP17A1 through Molecular Dynamics
    Xiao, Fei
    Yang, Maohua
    Xu, Youjun
    Vongsangnak, Wanwipa
    COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL, 2015, 13 : 520 - 527
  • [36] A bypass mechanism of abiraterone-resistant prostate cancer: Accumulating CYP17A1 substrates activate androgen receptor signaling
    Moll, Jan M.
    Kumagai, Jinpei
    van Royen, Martin E.
    Teubel, Wilma J.
    van Soest, Robert J.
    French, Pim J.
    Homma, Yukio
    Jenster, Guido
    de Wit, Ronald
    van Weerden, Wytske M.
    PROSTATE, 2019, 79 (09): : 937 - 948
  • [37] Neuropeptides promote castration-resistant prostate cancer through intracrine androgen biosynthesis
    Yang, Joy C.
    Kung, Hsing-Jien
    Gao, Allen C.
    Evans, Christopher P.
    CANCER RESEARCH, 2011, 71
  • [38] ERG regulation of intracrine androgen production and castration-resistant prostate cancer progression
    Powell, Katelyn A.
    Semaan, Louie
    Maddipati, Krishna R.
    Conley-Lacomb, Katie
    Li, Yanfeng
    Cher, Michael
    Chinni, Sreenivasa R.
    CANCER RESEARCH, 2014, 74 (19)
  • [39] Circulating cell-free AR and CYP17A1 copy number variations may associate with outcome of metastatic castration-resistant prostate cancer patients treated with abiraterone
    S Salvi
    V Casadio
    V Conteduca
    S L Burgio
    C Menna
    E Bianchi
    L Rossi
    E Carretta
    C Masini
    D Amadori
    D Calistri
    G Attard
    U De Giorgi
    British Journal of Cancer, 2015, 112 : 1717 - 1724
  • [40] Circulating cell-free AR and CYP17A1 copy number variations may associate with outcome of metastatic castration-resistant prostate cancer patients treated with abiraterone
    Salvi, S.
    Casadio, V.
    Conteduca, V.
    Burgio, S. L.
    Menna, C.
    Bianchi, E.
    Rossi, L.
    Carretta, E.
    Masini, C.
    Amadori, D.
    Calistri, D.
    Attard, G.
    De Giorgi, U.
    BRITISH JOURNAL OF CANCER, 2015, 112 (10) : 1717 - 1724
12345